AbbVie
ABBV
#27
Rank
โ‚น35.422 T
Marketcap
โ‚น20,027
Share price
1.78%
Change (1 day)
13.85%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Net assets

Net assets on the balance sheet as of December 2025 : -โ‚น303.34 Billion

According to AbbVie's latest financial reports the company has -โ‚น303.34 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

AbbVie - Net assets on balance sheet (from 2011 to 2025)

Net assets by year

Year Net assets Change
2025-12-31$-โ‚น289.78 Billion-200.41%
2024-12-31$โ‚น288.58 B-66.66%
2023-12-31$โ‚น865.53 B-39.49%
2022-12-31$โ‚น1.430 T24.51%
2021-12-31$โ‚น1.148 T19.95%
2020-12-31$โ‚น957.83 B-264.36%
2019-12-31$-โ‚น582.76 Billion-1.32%
2018-12-31$-โ‚น590.57 Billion-281.46%
2017-12-31$โ‚น325.44 B3.3%
2016-12-31$โ‚น315.03 B20.17%
2015-12-31$โ‚น262.16 B137.46%
2014-12-31$โ‚น110.40 B-60.22%
2013-12-31$โ‚น277.51 B50.71%
2012-12-31$โ‚น184.13 B-70.83%
2011-12-31$โ‚น631.20 B-10.3%
2010-12-31$โ‚น703.65 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Pfizer
PFE
โ‚น8.154 T-2,788.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2.493 T-922.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น813.59 B-368.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น1.715 T-665.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น2.125 T-800.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น1.739 T-673.30%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น4.578 T-1,609.26%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚น2.019 T-765.68%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
โ‚น305.69 B-200.78%๐Ÿ‡บ๐Ÿ‡ธ USA